Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

QuidelOrtho Corp (QDEL)

$16.05 -3.20% NASDAQ: QDEL · 15-min delayed
  • SAN DIEGO, California
  • Public · NASDAQ: QDEL
  • 6,500 employees
$977.2MMarket cap
$2.7BRevenue · FY2025
-$1.1BNet income
6,500Employees
QDELNASDAQ
1981IPO

About QuidelOrtho Corp

QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2025
$2.7B
Net income
-$1.1B
Total assets
$5.8B
Market cap
$977.2M
Operating margin
-33.7%
Net margin
-41.5%

Source: SEC EDGAR · updated Jun 7, 2026

Multi-year

Revenue & profit trend

Revenue Net income
FY 2025

Financial statements

Income statement

Revenue
$2.7B
Operating expenses
$3.6B
Operating income
-$919.2M
Income tax
$24.1M
Net income
-$1.1B
EPS (basic)
$-16.69
EPS (diluted)
$-16.69

Balance sheet

Total assets
$5.8B
Current assets
$1.4B
Total liabilities
$3.8B
Current liabilities
$966.1M
Shareholders’ equity
-$15.4M

Cash flow

Operating cash flow
$105.2M
Investing cash flow
-$192.7M
Financing cash flow
$155.8M
Net cash flow
$71.3M

Statements via Polygon.io (SEC filings)

NASDAQ: QDEL
$16.05 -3.20%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$9.96 $35.38

52-week range

Market cap
$977.2M
EPS (diluted)
$-16.69
Shares outstanding
60.9M
Open
Day range
Prev close
Volume
IPO date
Aug 4, 1981

QuidelOrtho Corp (QDEL) Stock Price

  • Reported a net loss of $1.1B in FY2025.
  • Revenue grew 64% from FY2020 to FY2025.
  • Trading 55% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review QuidelOrtho Corp.

Write a review
Newsroom

News about QuidelOrtho Corp

News & sentiment via Polygon.io

FAQ

QuidelOrtho Corp: frequently asked questions

Is QuidelOrtho Corp an American company?

QuidelOrtho Corp is a US-based company headquartered in San Diego, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Where is QuidelOrtho Corp headquartered?

QuidelOrtho Corp is headquartered in San Diego, California, United States.

Is QuidelOrtho Corp publicly traded?

Yes — QuidelOrtho Corp is a publicly traded company. Its stock trades under the ticker symbol QDEL on the NASDAQ.

What does QuidelOrtho Corp do?

QuidelOrtho Corp is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →